A meta-analysis published in a BMJ Group journal examines the relationship between the consumption of ultra-processed foods (UPFs) and various chronic health issues. The study suggests a dose-response relationship, but how researchers define a "dose" significantly affects their conclusions.
Read More
This analysis focused on prospective studies involving nearly 9 million adults, narrowed from over 10,000 reports to 51 relevant studies. These studies, primarily from Europe and the United States, investigated various health outcomes, including cardiovascular disease, cancer, all-cause mortality, hypertension, metabolic syndrome, diabetes, obesity, and mental health conditions.
Despite the large sample size, the overall evidence was rated as low certainty due to factors such as self-reported dietary intake and the NOVA classification, which groups nutritionally diverse foods as UPFs. Although most studies were deemed to have a low risk of bias, inconsistencies in accounting for lifestyle confounders added further uncertainty.
The analysis revealed several key findings. The highest consumption of UPFs was associated with a 23% increased risk of obesity, while metabolic syndrome and diabetes showed a 24% increased risk. Cancer risk rose by 12%, and all-cause mortality was 18% higher in the highest UPF consumers compared to the lowest. However, hypertension showed no significant association.
A central question the study raises is how to quantify UPF intake. Researchers employed different measurement methods, such as servings per week, grams per day, and dietary proportion. These varied metrics can yield substantially different risk estimates. For example, a 10-percentage-point increase in UPF intake as a proportion of total diet was linked to a modest 3% increase in cardiovascular risk.
In examining chronic illnesses related to diet, such as obesity, the relationship weakened when accounting for participants' initial body mass index (BMI), suggesting that baseline weight influences the observed association. Conversely, for metabolic syndrome, an increase of 100 grams of UPFs per day was linked to just a 2% increase in risk, while a dietary proportion increase led to a 16% rise.
Ultimately, while the study establishes a correlation between higher UPF intake and several chronic diseases, it does not clarify how much risk is associated with consuming additional UPFs, leaving questions about the extent of risk posed by individual servings or specific foods, such as cookies, unresolved.
The findings highlight the need for cautious interpretation, emphasizing moderation in consuming such foods and avoiding sensational headlines.